I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Acalabrutinib Lenalidomide and Rituximab for the Treatment of CD20 Positive Stage III-IV Grade 1-3a Follicular Lymphoma
This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicular lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide, work …
monoclonal antibodies
rituximab
bone marrow procedure
stage iv grade 2 follicular lymphoma
stage iv grade 1 follicular lymphoma
- 0 views
- 19 Feb, 2024